JENNIFER MILLER: Open Payments
NPI 1265925358 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,636 in 145 payments from 26 companies in 2025. Trend: 2023 $44 · 2024 $480 · 2025 $3,636
Food & beverage: $3,636
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $840 |
| GlaxoSmithKline, LLC. | 27 | $251 |
| GENZYME CORPORATION | 11 | $249 |
| ZOLL Respicardia, Inc. | 4 | $235 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $207 |
| Regeneron Healthcare Solutions, Inc. | 7 | $201 |
| Lilly USA, LLC | 6 | $194 |
| Insmed, Inc. | 11 | $181 |
| JAZZ PHARMACEUTICALS INC. | 7 | $175 |
| Pulmonx Corporation | 1 | $150 |
Products named: DUPIXENT, AIRSUPRA, remede System, ZEPBOUND, FASENRA, Arikayce, XYWAV, BREZTRI.
Industry payments across TN — which companies pay providers there.
